Medacta Group SA (MEDGF) Stock Statistics & Valuation Metrics

Medacta Group SA has a market cap or net worth of $3.95B. The enterprise value is $3.66B.

Medacta Group SA has 20,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medacta Group SA’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 11.90%.

The current PE Ratio of Medacta Group SA is 34.9. Medacta Group SA’s PEG ratio is 1.10.

In the last 12 months, Medacta Group SA had revenue of 688.27M and earned 96.12M in profits. Earnings per share was 4.81.

In the last 12 months, operating cash flow was 152.08M and capital expenditures -122.53M, giving a free cash flow of 29.56M billion.

Medacta Group SA pays an annual dividend of $0.409, resulting in a dividend yield of 0.41%

Medacta Group SA upcoming earnings date is Sep 4, 2026, TBA (Confirmed).

Medacta Group SA as a current ratio of 2.08, with Debt / Equity ratio of 60.01%

In the past 12 months, Medacta Group SA has paid 19.96M in taxes.

Medacta Group SA EV to EBITDA ratio is 18.83, with an EV/FCF ratio of 120.02.

Medacta Group SA has $33.19M in cash and marketable securities with $262.56M in debt, giving a net cash position of -$229.38M billion.

Gross margin is 66.70%, with operating margin of 16.80%, and net profit margin of 13.97%.

The average price target for Medacta Group SA is $210.88, which is 11.43% higher than the current price. The consensus rating is Moderate Buy